Micro Emerging Active

Sentimen analis Allogene Therapeutics

Narasi baru dengan cakupan terbatas — masih terbentuk.

Skor
0,2
Kecepatan
▲ 0,0
Artikel
3
Sumber
1

Linimasa Sentimen

Linimasa Peristiwa

Mei 02, 2026
Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock Neutral
Apr 24, 2026
H.C. Wainwright Maintains Buy Rating on Allogene Therapeutics (ALLO) Bullish
Apr 12, 2026
Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)? Neutral

Lini Waktu

Pertama TerlihatMei 02, 2026
Terakhir DiperbaruiAgu 27, 2026